全文获取类型
收费全文 | 42681篇 |
免费 | 4447篇 |
国内免费 | 1199篇 |
专业分类
耳鼻咽喉 | 196篇 |
儿科学 | 1771篇 |
妇产科学 | 350篇 |
基础医学 | 5286篇 |
口腔科学 | 619篇 |
临床医学 | 4654篇 |
内科学 | 9734篇 |
皮肤病学 | 937篇 |
神经病学 | 2272篇 |
特种医学 | 671篇 |
外国民族医学 | 4篇 |
外科学 | 2795篇 |
综合类 | 6848篇 |
现状与发展 | 4篇 |
一般理论 | 1篇 |
预防医学 | 3278篇 |
眼科学 | 501篇 |
药学 | 4070篇 |
27篇 | |
中国医学 | 3126篇 |
肿瘤学 | 1183篇 |
出版年
2024年 | 74篇 |
2023年 | 959篇 |
2022年 | 1073篇 |
2021年 | 2172篇 |
2020年 | 2077篇 |
2019年 | 1790篇 |
2018年 | 1725篇 |
2017年 | 1824篇 |
2016年 | 1944篇 |
2015年 | 1764篇 |
2014年 | 3245篇 |
2013年 | 3360篇 |
2012年 | 3069篇 |
2011年 | 3189篇 |
2010年 | 2407篇 |
2009年 | 2268篇 |
2008年 | 2175篇 |
2007年 | 1968篇 |
2006年 | 1694篇 |
2005年 | 1493篇 |
2004年 | 1168篇 |
2003年 | 937篇 |
2002年 | 786篇 |
2001年 | 710篇 |
2000年 | 558篇 |
1999年 | 479篇 |
1998年 | 437篇 |
1997年 | 363篇 |
1996年 | 291篇 |
1995年 | 269篇 |
1994年 | 243篇 |
1993年 | 231篇 |
1992年 | 229篇 |
1991年 | 171篇 |
1990年 | 149篇 |
1989年 | 131篇 |
1988年 | 115篇 |
1987年 | 114篇 |
1986年 | 99篇 |
1985年 | 119篇 |
1984年 | 82篇 |
1983年 | 57篇 |
1982年 | 67篇 |
1981年 | 53篇 |
1980年 | 44篇 |
1979年 | 34篇 |
1978年 | 27篇 |
1977年 | 25篇 |
1976年 | 25篇 |
1974年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 546 毫秒
1.
2.
3.
4.
5.
6.
7.
《Journal of infection and chemotherapy》2022,28(4):548-553
IntroductionCOVID-19 patients have been reported to have digestive symptoms with poor outcome. Ivermectin, an antiparasitic drug, has been used in COVID-19 patients. The objective of this study was to evaluate whether ivermectin has effects on gastrointestinal complications and ventilator-free days in ventilated patients with COVID-19.MethodsCOVID-19 patients who were mechanically ventilated in the ICU were included in this study. The ventilated patients who received ivermectin within 3 days after admission were assigned to the Ivermectin group, and the others were assigned to the Control group. Patients in the Ivermectin group received ivermectin 200 μg/kg via nasal tube. The incidence of gastrointestinal complications and ventilator-free days within 4 weeks from admission were evaluated as clinical outcomes using a propensity score with the inverse probability weighting method.ResultsWe included 88 patients in this study, of whom 39 patients were classified into the Ivermectin group, and 49 patients were classified into the Control group. The hazard ratio for gastrointestinal complications in the Ivermectin group as compared with the Control group was 0.221 (95% confidence interval [CI], 0.057 to 0.855; p = 0.029) in a Cox proportional-hazard regression model. The odds ratio for ventilator-free days as compared with the Control group was 1.920 (95% CI, 1.076 to 3.425; p = 0.027) in a proportional odds logistic regression model.ConclusionsIvermectin improved gastrointestinal complications and the number of ventilator-free days in severe COVID-19 patients undergoing mechanical ventilation. Prevention of gastrointestinal symptoms by SARS-Cov-2 might be associated with COVID-19 outcome. 相似文献
8.
9.
《Journal of pediatric surgery》2023,58(5):856-861
Background/PurposeA small number of Hirschsprung disease (HD) patients develop inflammatory bowel disease (IBD)-like symptoms after pullthrough surgery. The etiology and pathophysiology of Hirschsprung-associated IBD (HD-IBD) remains unknown. This study aims to further characterize HD-IBD, to identify potential risk factors and to evaluate response to treatment in a large group of patients.MethodsRetrospective study of patients diagnosed with IBD after pullthrough surgery between 2000 and 2021 at 17 institutions. Data regarding clinical presentation and course of HD and IBD were reviewed. Effectiveness of medical therapy for IBD was recorded using a Likert scale.ResultsThere were 55 patients (78% male). 50% (n = 28) had long segment disease. Hirschsprung-associated enterocolitis (HAEC) was reported in 68% (n = 36). Ten patients (18%) had Trisomy 21. IBD was diagnosed after age 5 in 63% (n = 34). IBD presentation consisted of colonic or small bowel inflammation resembling IBD in 69% (n = 38), unexplained or persistent fistula in 18% (n = 10) and unexplained HAEC >5 years old or unresponsive to standard treatment in 13% (n = 7). Biological agents were the most effective (80%) medications. A third of patients required a surgical procedure for IBD.ConclusionMore than half of the patients were diagnosed with HD-IBD after 5 years old. Long segment disease, HAEC after pull through operation and trisomy 21 may represent risk factors for this condition. Investigation for possible IBD should be considered in children with unexplained fistulae, HAEC beyond the age of 5 or unresponsive to standard therapy, and symptoms suggestive of IBD. Biological agents were the most effective medical treatment.Level of EvidenceLevel 4 相似文献
10.
《The Journal for Nurse Practitioners》2022,18(2):245-247
Transient stress hyperglycemia in the setting of acute myocardial infarction is a frequent phenomenon. Its transient nature should not dissuade the clinician from management of elevated blood glucose in a patient after an ST-elevation myocardial infarction. This case presents an adult patient after an ST-elevation myocardial infarction with transient stress hyperglycemia and the evidence used to identify optimal pharmacologic management and secondary prevention. 相似文献